A detailed history of Janus Henderson Group PLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 36,873 shares of RLAY stock, worth $239,305. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,873
Previous 37,342 1.26%
Holding current value
$239,305
Previous $309,000 22.33%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$5.9 - $8.02 $2,767 - $3,761
-469 Reduced 1.26%
36,873 $240,000
Q1 2024

May 15, 2024

BUY
$7.5 - $12.07 $217 - $350
29 Added 0.08%
37,342 $309,000
Q4 2023

Feb 14, 2024

SELL
$6.01 - $11.48 $348 - $665
-58 Reduced 0.16%
37,313 $410,000
Q3 2023

Nov 14, 2023

SELL
$8.24 - $12.97 $24 - $38
-3 Reduced 0.01%
37,371 $314,000
Q2 2023

Aug 14, 2023

SELL
$9.99 - $18.27 $459 - $840
-46 Reduced 0.12%
37,374 $469,000
Q1 2023

May 15, 2023

BUY
$15.0 - $22.76 $286,350 - $434,488
19,090 Added 104.15%
37,420 $616,000
Q4 2022

Feb 14, 2023

BUY
$14.16 - $24.02 $87,792 - $148,924
6,200 Added 51.11%
18,330 $273,000
Q3 2022

Nov 14, 2022

SELL
$18.07 - $31.37 $84,061 - $145,933
-4,652 Reduced 27.72%
12,130 $271,000
Q2 2022

Aug 15, 2022

BUY
$13.31 - $34.88 $223,368 - $585,356
16,782 New
16,782 $281,000
Q4 2021

Feb 14, 2022

SELL
$26.0 - $37.03 $442,104 - $629,658
-17,004 Closed
0 $0
Q3 2021

Nov 16, 2021

SELL
$29.75 - $37.99 $215,271 - $274,895
-7,236 Reduced 29.85%
17,004 $534,000
Q2 2021

Aug 16, 2021

SELL
$27.5 - $38.19 $1.89 Million - $2.62 Million
-68,690 Reduced 73.92%
24,240 $884,000
Q1 2021

May 17, 2021

SELL
$32.52 - $61.53 $167,868 - $317,617
-5,162 Reduced 5.26%
92,930 $3.21 Million
Q4 2020

Feb 16, 2021

SELL
$35.51 - $54.03 $13.8 Million - $21 Million
-388,519 Reduced 79.84%
98,092 $4.08 Million
Q3 2020

Nov 16, 2020

BUY
$32.81 - $45.1 $16 Million - $21.9 Million
486,611 New
486,611 $20.7 Million

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $780M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.